Trial Details

UNKNOWN
Basic Information
Clinical ID c1372
Identifier NCT02768974
Trial Title Open Label Study to Assess Safety, PK and Explore Efficacy of OPRX-106 in Patients With Active Mild to Moderate Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: OPRX-106
Participant Information
Sponsor Protalix
City Be'er-Sheva
Country/Region Israel
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2025-09-16
Primary Completion Date 2025-02-17
Completion Date -